ClinicalTrials.gov record
Enrolling by invitation Phase 4 Interventional

Antibiotic Prophylaxis in Pediatric Open Fractures

ClinicalTrials.gov ID: NCT06055712

Public ClinicalTrials.gov record NCT06055712. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06055712
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 4
Lead sponsor
St. Louis University
Other
Enrollment
800 participants

Conditions and interventions

Interventions

  • Cefazolin Drug
  • Cephalexin Drug

Drug

Eligibility (public fields only)

Age range
0 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 10, 2023
Primary completion
Aug 31, 2033
Completion
Dec 31, 2033
Last update posted
Oct 19, 2025

2023 – 2034

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Saint Louis University St Louis Missouri 63110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06055712, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06055712 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →